• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hypertension and Histopathology Severity of Non-Alcoholic Fatty Liver Disease Among Adults with Obesity: A Cross-Sectional Study.肥胖成年人中非酒精性脂肪性肝病的高血压与组织病理学严重程度:一项横断面研究
Clin Exp Gastroenterol. 2023 Aug 14;16:129-136. doi: 10.2147/CEG.S402498. eCollection 2023.
2
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
3
Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.非酒精性脂肪肝与心血管代谢危险因素的关系:横断面研究。
Biol Sex Differ. 2022 Nov 4;13(1):64. doi: 10.1186/s13293-022-00475-7.
4
[The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].[成人隐匿性自身免疫性糖尿病患者非酒精性脂肪性肝病与代谢综合征的关系]
Zhonghua Yi Xue Za Zhi. 2018 Aug 14;98(30):2398-2402. doi: 10.3760/cma.j.issn.0376-2491.2018.30.006.
5
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.年龄在 45-60 岁的中国人群中,非酒精性脂肪肝与高血压之间的相关性存在性别差异。
Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28.
6
Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.肥胖儿童的非酒精性脂肪性肝病与代谢综合征标准之间的关系。
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e356-63. doi: 10.1016/j.orcp.2013.08.003. Epub 2013 Sep 7.
7
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.韩国成年人中,根据体重指数,非酒精性脂肪性肝病与代谢综合征各组分的关系。
Am J Gastroenterol. 2012 Dec;107(12):1852-8. doi: 10.1038/ajg.2012.314. Epub 2012 Oct 2.
8
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.反应性充血指数 (RHI) 和认知表现指数与非酒精性脂肪性肝病 (NAFLD) 患者的肝脏疾病组织学标志物相关:一项病例对照研究。
Cardiovasc Diabetol. 2018 Feb 16;17(1):28. doi: 10.1186/s12933-018-0670-7.
9
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.脂肪肝进展算法和脂肪变性、活动度及纤维化评分在评估非酒精性脂肪肝对未经治疗的慢性乙型肝炎患者影响中的应用。
Front Cell Infect Microbiol. 2022 Jan 17;11:733348. doi: 10.3389/fcimb.2021.733348. eCollection 2021.
10
Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.代谢综合征及其组分作为中国北方城市汉族人群非酒精性脂肪性肝病预测因素的前瞻性队列研究
Atherosclerosis. 2015 May;240(1):144-8. doi: 10.1016/j.atherosclerosis.2015.02.049. Epub 2015 Mar 11.

引用本文的文献

1
A Study on Prevalence and Factors Affecting Hypertension in an Iranian Population: Results from the Fasa Cohort Study.伊朗人群高血压患病率及影响因素研究:法萨队列研究结果
Med J Islam Repub Iran. 2024 Oct 23;38:123. doi: 10.47176/mjiri.38.123. eCollection 2024.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.日本代谢相关脂肪性肝病:2019 年冠状病毒病大流行前 10 年的流行趋势及临床背景。
Medicina (Kaunas). 2024 Aug 16;60(8):1330. doi: 10.3390/medicina60081330.

本文引用的文献

1
Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension.非酒精性脂肪性肝病中的亚临床和临床动脉粥样硬化与高血压的存在有关。
Nutr Metab Cardiovasc Dis. 2022 Dec;32(12):2839-2847. doi: 10.1016/j.numecd.2022.08.005. Epub 2022 Aug 11.
2
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.肥胖的病理生理分子机制:MAFLD 和 NASH 与心血管疾病的联系。
Int J Mol Sci. 2021 Oct 27;22(21):11629. doi: 10.3390/ijms222111629.
3
The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.非酒精性脂肪性肝病与心血管疾病、中风及肝外癌症风险之间的关联
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):45-81. doi: 10.1016/j.jceh.2020.04.018. Epub 2020 May 20.
4
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments.非酒精性脂肪性肝炎:其发病机制、模型及医学治疗的综述
Front Pharmacol. 2020 Dec 3;11:603926. doi: 10.3389/fphar.2020.603926. eCollection 2020.
5
The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.降压药肼屈嗪可减少高血压加重的非酒精性脂肪性肝炎患者的细胞外基质合成和肝纤维化。
PLoS One. 2020 Dec 14;15(12):e0243846. doi: 10.1371/journal.pone.0243846. eCollection 2020.
6
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.非酒精性脂肪性肝病作为一个连续体:从肥胖到代谢综合征及糖尿病。
Diabetol Metab Syndr. 2020 Jul 14;12:60. doi: 10.1186/s13098-020-00570-y. eCollection 2020.
7
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories.美国成年人中不同血压类别中非酒精性脂肪肝疾病和肝纤维化的进展。
Hypertension. 2020 Aug;76(2):562-568. doi: 10.1161/HYPERTENSIONAHA.120.15220. Epub 2020 Jun 29.
8
A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults.韩国健康成年人非酒精性脂肪性肝病标志物与新发高血压之间的密切关系。
Korean Circ J. 2020 Aug;50(8):695-705. doi: 10.4070/kcj.2019.0379. Epub 2020 Mar 23.
9
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.FLIP算法和SAF评分在非酒精性脂肪性肝病患者中的临床验证。
J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17.
10
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.代谢特征对非酒精性脂肪性肝病患者肝硬化和肝细胞癌风险的影响。
Hepatology. 2020 Mar;71(3):808-819. doi: 10.1002/hep.31014. Epub 2020 Feb 26.

肥胖成年人中非酒精性脂肪性肝病的高血压与组织病理学严重程度:一项横断面研究

Hypertension and Histopathology Severity of Non-Alcoholic Fatty Liver Disease Among Adults with Obesity: A Cross-Sectional Study.

作者信息

Chambergo-Michilot Diego, Rodrigo-Gallardo Paola K, Huaman Mariella R, Vasquez-Chavesta Angie Z, Salinas-Sedo Gustavo, Toro-Huamanchumo Carlos J

机构信息

Universidad Científica del Sur, Lima, Peru.

Hospital Docente Las Mercedes, Chiclayo, Peru.

出版信息

Clin Exp Gastroenterol. 2023 Aug 14;16:129-136. doi: 10.2147/CEG.S402498. eCollection 2023.

DOI:10.2147/CEG.S402498
PMID:37601009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10437097/
Abstract

BACKGROUND

Cardiovascular diseases are responsible for the majority of deaths resulting from non-alcoholic fatty liver disease (NAFLD). NAFLD is associated with hypertension and this is a key predictor of severe liver outcomes and an indicator of nonspecific portal fibrosis.

AIM

To assess the association between hypertension and NAFLD severity.

METHODS

We conducted a secondary analysis of data from Peruvian adults with obesity and NAFLD who attended a Peruvian bariatric center. The severity of NAFLD was assessed using the Fatty Liver Inhibition of Progression algorithm / Steatosis, Activity and Fibrosis score. Hypertension was determined by either being recorded in the medical records or if the patient had a systolic pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg. To evaluate the association of interest, we calculated crude and adjusted prevalence ratios (aPR) using Poisson generalized linear models with logarithmic link function and robust variances. For the multivariable models, we adjusted for age, sex, physical activity and smoking.

RESULTS

Our study included 234 participants. The prevalence of hypertension was 19.2%, while the prevalence of severe NAFLD was 46.2%. After adjusting for confounders, the prevalence of hypertension was found to be significantly higher in the severe NAFLD group compared to the non-severe group (aPR = 1.33; 95% CI: 1.03-1.74). When stratified by the presence of metabolic syndrome (MetS), the association remained significant only in the group without MetS (aPR = 1.80; 95% CI: 1.05-3.11).

CONCLUSION

We found an association between hypertension and severe NAFLD in adults with obesity, particularly in those without MetS.

摘要

背景

心血管疾病是导致非酒精性脂肪性肝病(NAFLD)死亡的主要原因。NAFLD与高血压相关,这是严重肝脏结局的关键预测因素和非特异性门静脉纤维化的指标。

目的

评估高血压与NAFLD严重程度之间的关联。

方法

我们对秘鲁一家减肥中心的肥胖和NAFLD成年秘鲁人数据进行了二次分析。使用脂肪肝进展抑制算法/脂肪变性、活动和纤维化评分评估NAFLD的严重程度。高血压通过病历记录确定,或者如果患者收缩压≥140 mmHg或舒张压≥90 mmHg。为了评估感兴趣的关联,我们使用具有对数链接函数和稳健方差的泊松广义线性模型计算了粗患病率和调整患病率比(aPR)。对于多变量模型,我们对年龄、性别、身体活动和吸烟进行了调整。

结果

我们的研究包括234名参与者。高血压患病率为19.2%,而严重NAFLD患病率为46.2%。在调整混杂因素后,发现严重NAFLD组的高血压患病率显著高于非严重组(aPR = 1.33;95% CI:1.03 - 1.74)。按代谢综合征(MetS)的存在进行分层时,该关联仅在无MetS的组中仍然显著(aPR = 1.80;95% CI:1.05 - 3.11)。

结论

我们发现肥胖成年人中高血压与严重NAFLD之间存在关联,尤其是在无MetS的成年人中。